Kali Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Kali Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA) (NCT07564154) | Kali Therapeutics, Inc. | 2026-07-13 |
| A First-in-human Study of KT501 Administered Subcutaneously to Patients With Rheumatoid Arthritis (RA). (NCT07234773) | Kali Therapeutics, Inc. | 2026-03-06 |
Track Kali Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.